How Much Does Imbruvica Cost?

Our most recent US pharmacy data shows a low of roughly $9,695.31 for Imbruvica with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.

We found Canadian pricing for Imbruvica starting near $11.90 per tablet in USD terms. That's before any shipping charge, which the table above breaks out separately.

Drug pricing is set separately in each country through different negotiation, regulatory, and distribution systems, so the same medication can legitimately carry different price tags on either side of the border. Check the comparison table above for the specific numbers on Imbruvica.

Generic and brand-name pricing for Imbruvica is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.

Imbruvica is a brand-name medication containing the active ingredient ibrutinib. A generic equivalent, or generic ibrutinib, is not currently on the market.

Imbruvica is a brand-name prescription drug approved to treat several types of blood cancers, including mantle cell lymphoma, chronic lymphocytic leukemia, marginal zone lymphoma, and small lymphocytic lymphoma. These conditions are characterized by the overproduction of abnormal white blood cells (lymphocytes). It is also used for Waldenstrom's macroglobulinemia, a similar cancer where defective cells overproduce antibodies, potentially thickening the blood. Additionally, Imbruvica can treat chronic graft-versus-host disease, a complication of bone marrow transplants where donor cells attack the patient's tissues. Its active ingredient, ibrutinib, is classified as a tyrosine kinase inhibitor. It works by blocking a specific protein (a tyrosine kinase) that signals cells to divide. This protein is often overactive in cancer cells, so inhibiting it can slow or halt tumor growth. Treatment typically involves taking a capsule or tablet once daily, continuing until there is adequate therapeutic progress or until treatment is no longer tolerated. Consult your doctor for personalized medical advice.

Common side effects of Imbruvica can include nausea, diarrhea, constipation, bruising, indigestion, headache, dizziness, cough, shortness of breath, fever, swelling, joint or muscle pain, muscle spasms, anemia, decreased appetite, dehydration, fatigue, and hand-foot skin reaction (characterized by stinging, tingling, pain, dryness, cracking, thickening, swelling, or blistering on palms and soles). More serious potential effects include low platelet counts (increasing bleeding risk), high blood pressure, an elevated risk of infections and other cancers, and tumor lysis syndrome. Tumor lysis syndrome is a dangerous condition where the rapid death of cancer cells releases their contents into the bloodstream, potentially leading to kidney failure, abnormal electrolyte levels, heart issues, or seizures. Allergic reactions are rare but require immediate medical attention; watch for signs like fever, sore throat, swelling, itching, or rash and contact your doctor promptly.